HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hi-Tech CEO Wheat Arrested In FDA Investigation Of Steroid-Spiked Supplements

This article was originally published in The Rose Sheet

Executive Summary

Hi-Tech Pharmaceuticals CEO Jared Wheat and an associate face 18 criminal charges in federal court alleging they falsified FDA documents and distributed as supplements products containing steroid ingredient. Wheat is appealing the indictment to federal circuit court.

You may also be interested in...

As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint

Hi-Tech Pharmaceuticals granted motion in federal court to have $19m in seized DMAA products returned, though the order noted sales of the products are prohibited. As Hi-Tech seeks court order that FDA is wrong about DMAA, an appellate court upholds $40m contempt fine against firm in FTC complaint.

Health, Beauty And Wellness News: GNC, Momentous, Nutrition 21, Gaspari

GNC online sourcing deal; Gaspari CEO has full control of brand; medical cannabis research partnership in Canada; Momentous occasion of plant protein launch; Innotech Nutrition in US with Colflex preventative spray; AMP Energy wants entrepreneurs; and Nutrition 21's Nitrosigine in C4 Ultimate Shred.

Five Shanghai Suspects Charged After FDA Undercover Work On Spiked Supplements

One of the undeclared stimulant ingredients, 2-amino-6-methylheptane, or DMHA, is new on FDA's radar for violative ingredients used in products marketed as dietary supplements, while the other, 1,3-dimethylamylamine, DMAA, has long been a target of agency enforcement in the supplement sector.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts